<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00543881</url>
  </required_header>
  <id_info>
    <org_study_id>01MG531</org_study_id>
    <nct_id>NCT00543881</nct_id>
  </id_info>
  <brief_title>Telemedical Interventional Monitoring in Heart Failure</brief_title>
  <acronym>TIM-HF</acronym>
  <official_title>Telemedical Interventional Monitoring in Heart Failure (TIM-HF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Federal Ministry of Economics and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Superiority of additional Remote Patient Monitoring in patients with CHF In comparison to
      usual care in terms of:

        -  reduction of mortality rate

        -  reduction of hospitalizations

        -  increasement of patients' quality of life
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The clinical trial assesses 710 patients over a period of at least 15 months each (2008 until
      2010); all participants will continue to receive usual care from their GP. All patients will
      be examined at the beginning of the study and will undergo a check-up every 3 months. 355 of
      the patients will be randomly allocated to receive devices for Remote Patient Monitoring
      which will measure various parameters on a daily basis (e.g., weight, blood pressure, heart
      rate). The devices are mobile and can be used at home or elsewhere.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>all cause mortality</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>comp of the combined rate of cv death and hosp. for worsening HF;days lost due to cv death or HF hosp;cv mortality;Rate of cv hosp;Rate of hosp for HF;hosp for any reason;cv hosp;hosp for HF;duration of all hosp for HF;NYHA class; SF-36; PHQ-9 score</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">710</enrollment>
  <condition>Chronic Heart Failure</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Interventional group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual care group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Remote patient monitoring (Partnership for the Heart)</intervention_name>
    <description>Guideline-based care in heart failure (NYHA II-III) including at least 5 scheduled doctor's visits plus daily monitoring of ECG, weight, blood pressure, self-report of health status, weekly monitoring of physical fitness</description>
    <arm_group_label>1</arm_group_label>
    <other_name>brand name for remote patient monitoring system: Partnership for the Heart</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Usual care group</intervention_name>
    <description>Guideline-based care in heart failure (NYHA II-III) including at least 5 scheduled doctor's visits</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Ambulatory CHF NYHA II or III

          2. LVEF ≤ 35% and cardiac decompensation with hospitalization for heart failure or
             therapy with intravenous diuretics (.40 mg furosemide/day) within 24 months prior to
             enrolment or LVEF ≤ 25%, measured twice within past 6 months

          3. Optimal medical treatment for CHF (b-blocker, ACE-inhibitor/ ARB, diuretics) including
             ICD/CRT if indicated

          4. Age ≥ 18 years

          5. Informed consent

        Exclusion Criteria:

          1. Existence of any disease (HF excluded) reducing life expectancy to less than 1 year

          2. Insufficient compliance to telemonitoring or study visits

          3. Impairment to use the telemonitoring equipment or appear to study visits (e.g.
             dementia, impaired self-determination, lacking ability to communicate)

          4. Pregnancy

          5. Concurrent participation in other therapy trials

          6. Hospitalization for cardiac decompensation within 7 days before inclusion in trial

          7. Implanted cardiac assist system

          8. Unstable angina pectoris

          9. Congenital heart defect

         10. Primary heart valve disease

         11. Hypertrophic or restrictive cardiomyopathy

         12. Arrhythmogenic right ventricular cardiomyopathy

         13. Acute myocarditis diagnosis ,1 year

         14. Actively listed for heart transplantation

         15. Planned revascularization or CRT implantation

         16. Chronic renal insufficiency with creatinine .2.5 mg/dl

         17. Liver cirrhosis

         18. Known alcohol or drug abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Friedrich Koehler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charité - Universitaetsmedizin Berlin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charité - Universitaetsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Robert-Bosch-Krankenhaus</name>
      <address>
        <city>Stuttgart</city>
        <zip>70376</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://telemedizin.charite.de/en</url>
  </link>
  <reference>
    <citation>Koehler F, Anker SD. Noninvasive home telemonitoring: the Trans-European Network-Home-Care Management System. J Am Coll Cardiol. 2006 Aug 15;48(4):850-1; author reply 851-2. Epub 2006 Jul 24.</citation>
    <PMID>16904569</PMID>
  </reference>
  <reference>
    <citation>Köhler F, Schieber M, Lücke S, Heinze P, Henke S, Matthesius G, Pferdt T, Wegertseder D, Stoll M, Anker SD. [&quot;Partnership for the Heart&quot;--development and testing of a new remote patient monitoring system]. Dtsch Med Wochenschr. 2007 Mar 2;132(9):458-60. German.</citation>
    <PMID>17315125</PMID>
  </reference>
  <reference>
    <citation>Winkler S, Schieber M, Lücke S, Heinze P, Schweizer T, Wegertseder D, Scherf M, Nettlau H, Henke S, Braecklein M, Anker SD, Koehler F. A new telemonitoring system intended for chronic heart failure patients using mobile telephone technology--feasibility study. Int J Cardiol. 2011 Nov 17;153(1):55-8. doi: 10.1016/j.ijcard.2010.08.038. Epub 2010 Sep 18.</citation>
    <PMID>20851481</PMID>
  </reference>
  <reference>
    <citation>Anker SD, Koehler F, Abraham WT. Telemedicine and remote management of patients with heart failure. Lancet. 2011 Aug 20;378(9792):731-9. doi: 10.1016/S0140-6736(11)61229-4. Review.</citation>
    <PMID>21856487</PMID>
  </reference>
  <reference>
    <citation>Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M, Boll H, Kim SS, Koehler K, Lücke S, Honold M, Heinze P, Schweizer T, Braecklein M, Kirwan BA, Gelbrich G, Anker SD; TIM-HF Investigators. Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design. Eur J Heart Fail. 2010 Dec;12(12):1354-62. doi: 10.1093/eurjhf/hfq199.</citation>
    <PMID>21098580</PMID>
  </reference>
  <results_reference>
    <citation>Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M, Boll H, Baumann G, Honold M, Koehler K, Gelbrich G, Kirwan BA, Anker SD; Telemedical Interventional Monitoring in Heart Failure Investigators. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation. 2011 May 3;123(17):1873-80. doi: 10.1161/CIRCULATIONAHA.111.018473. Epub 2011 Mar 28.</citation>
    <PMID>21444883</PMID>
  </results_reference>
  <results_reference>
    <citation>Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M, de Brouwer S, Perrin E, Baumann G, Gelbrich G, Boll H, Honold M, Koehler K, Kirwan BA, Anker SD. Telemedicine in heart failure: pre-specified and exploratory subgroup analyses from the TIM-HF trial. Int J Cardiol. 2012 Nov 29;161(3):143-50. doi: 10.1016/j.ijcard.2011.09.007. Epub 2011 Oct 8.</citation>
    <PMID>21982700</PMID>
  </results_reference>
  <results_reference>
    <citation>Prescher S, Deckwart O, Winkler S, Koehler K, Honold M, Koehler F. Telemedical care: feasibility and perception of the patients and physicians: a survey-based acceptance analysis of the Telemedical Interventional Monitoring in Heart Failure (TIM-HF) trial. Eur J Prev Cardiol. 2013 Jun;20(2 Suppl):18-24. doi: 10.1177/2047487313487483e.</citation>
    <PMID>23702987</PMID>
  </results_reference>
  <results_reference>
    <citation>Jehn M, Prescher S, Koehler K, von Haehling S, Winkler S, Deckwart O, Honold M, Sechtem U, Baumann G, Halle M, Anker SD, Koehler F. Tele-accelerometry as a novel technique for assessing functional status in patients with heart failure: feasibility, reliability and patient safety. Int J Cardiol. 2013 Oct 12;168(5):4723-8. doi: 10.1016/j.ijcard.2013.07.171. Epub 2013 Jul 25.</citation>
    <PMID>23962782</PMID>
  </results_reference>
  <results_reference>
    <citation>Prescher S, Deckwart O, Koehler K, Lücke S, Schieber M, Wellge B, Winkler S, Baumann G, Koehler F. [Will telemonitoring be adopted by patients with chronic heart failure?]. Dtsch Med Wochenschr. 2014 Apr;139(16):829-34. doi: 10.1055/s-0034-1369849. Epub 2014 Apr 10. German.</citation>
    <PMID>24722932</PMID>
  </results_reference>
  <results_reference>
    <citation>Prescher S, Schoebel C, Koehler K, Deckwart O, Wellge B, Honold M, Hartmann O, Winkler S, Koehler F. Prognostic value of serial six-minute walk tests using tele-accelerometry in patients with chronic heart failure: A pre-specified sub-study of the TIM-HF-Trial. Eur J Prev Cardiol. 2016 Oct;23(2 suppl):21-26.</citation>
    <PMID>27892422</PMID>
  </results_reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2007</study_first_submitted>
  <study_first_submitted_qc>October 12, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2007</study_first_posted>
  <last_update_submitted>December 20, 2016</last_update_submitted>
  <last_update_submitted_qc>December 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Friedrich Koehler</investigator_full_name>
    <investigator_title>Senior Physician</investigator_title>
  </responsible_party>
  <keyword>telemedicine</keyword>
  <keyword>remote patient monitoring</keyword>
  <keyword>chronic heart failure</keyword>
  <keyword>mortality</keyword>
  <keyword>health economics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

